Investor FAQs

In This Section

Breadcrumb

Home // Investors // Investor FAQs //

Investor FAQs

Show All
When was Novelion Therapeutics founded?

In November 2016, Novelion was launched through a merger transaction in which Aegerion Pharmaceuticals became an indirect, wholly-owned subsidiary of QLT Inc. In conjunction with the closing of the merger, QLT changed its name to Novelion Therapeutics Inc. 

Where is Novelion's stock traded?

Novelion Therapeutics’ common stock is traded on the NASDAQ Global Select Market and the Toronto Stock Exchange under the ticker symbol "NVLN.” 

What is your stock's CUSIP number?

67001K103.

Where are Novelion Therapeutics' headquarters located?
887 Great Northern Way, Suite 250
Vancouver, BC V5T 4T5 
Canada 
Can I buy Novelion Therapeutics stock directly from the company?

Novelion does not offer a direct stock purchase plan. Shares of the Company should be purchased through a broker.

Does Novelion Therapeutics pay a dividend?

Novelion does not currently pay dividends.

Who is Novelion Therapeutics' transfer agent?
Computershare Shareholder Services
Toll Free:  800 368 5948
Toll: +1 (781) 575 4223
 
Shareholder correspondence should be mailed to:
Computershare
P.O. BOX 30170
College Station, TX 77845-3170
 
Overnight correspondence should be sent to:
Computershare
211 Quality Circle, Suite 210
College Station, TX 77842
 
Shareholder website
 
Shareholder online inquiries
 
Who do I contact about replacement of stock certificates?

To replace lost certificates, contact the transfer agent: www.rtco.com, a free web tool for shareholders.

I'm a shareholder; whom should I notify of a change in address?

To change address, contact the transfer agent: www.rtco.com, a free web tool for shareholders.

What is Novelion Therapeutics' fiscal year?
Novelion’s fiscal year is based on the calendar year.
First Quarter ends 3/31, Second Quarter ends 6/30, Third Quarter ends 9/30 and Fourth Quarter ends 12/31.